Innovative tools and diagnostic platforms are advancing early disease detection and research capabilities. Scripps Research scientists developed a microchip that rapidly maps antibody-virus interactions using minimal blood. OrisDx prepares to launch a saliva-based oral cancer test targeting early detection in dental settings. Personalis and Tempus AI extended their collaboration to include colorectal cancer for minimal residual disease testing. Additionally, a portable hybrid gamma-optical camera from Serac Imaging offers point-of-care gamma imaging with clinical utility in nuclear medicine and surgery.